Conversation with The Cancer Letter

Conversation with The Cancer Letter

Ben Ho Park wants Vanderbilt to deliver precision oncology in Tennessee—and globally
Conversation with The Cancer Letter

Ben Ho Park wants Vanderbilt to deliver precision oncology in Tennessee—and globally

As Ben Ho Park sees it, the mission of a cancer researcher doesn’t stop at the water’s edge. It follows that Park’s new role as director of Vanderbilt-Ingram Cancer Center is inseparable from his role as an executive of the Global Cancer Institute, a nonprofit that works with healthcare providers in low- and middle-income countries to improve survival rates for underserved cancer patients.
By Paul Goldberg
FDA spells out new systematic approach to giving out–and taking away–accelerated approvals in oncology
Conversation with The Cancer Letter

FDA spells out new systematic approach to giving out–and taking away–accelerated approvals in oncology

Companies vying for accelerated approval and devising strategies for confirmatory trials would be best served by seeking prospective sign-off from FDA, agency officials say.  Officials from the FDA Oncology Center of Excellence described these best practices in a perspective piece in the Sept. 21 issue of The New England Journal of Medicine and discussed the […]
By Paul Goldberg